Paeoniflorin attenuates high-fat diet-induced obesity by promoting white adipose tissue browning via the regulation of the AMPK/SIRT3 pathway

Obesity is a major global public health challenge. Induction of white adipose tissue (WAT) browning has emerged as a potential strategy to enhance energy expenditure and improve metabolic homeostasis. Paeoniflorin (PF), a natural monoterpene glycoside, exhibits diverse pharmacological activities; however, its effects on WAT browning remain unclear. This study aimed to investigate whether PF alleviates high-fat diet (HFD)-induced obesity and associated metabolic abnormalities by promoting WAT browning. Obesity was induced in C57BL/6 mice by HFD feeding, followed by oral administration of PF (100 or 200 mg/kg). Body weight, adipose tissue mass, blood glucose, serum insulin, and lipid profiles were evaluated. Adipocyte morphology and the expression of thermogenesis-related markers, including UCP1, PGC-1α, and PRDM16, were assessed by histological analysis, RT-qPCR, Western blotting, and immunofluorescence staining. Lipid accumulation was evaluated by Oil Red O staining. In vitro, 3T3-L1 cells were treated with PF during adipocyte differentiation to assess lipid accumulation and the expression of browning-related markers. The potential involvement of the AMPK/SIRT3 signaling pathway was further investigated using pharmacological inhibition of AMPK. PF treatment significantly attenuated HFD-induced obesity and metabolic abnormalities in a dose-dependent manner. Compared with the HFD group, final body weight was reduced by 5.6% and 9.8% following treatment with PF at 100 and 200 mg/kg, respectively. Fasting blood glucose levels were decreased by 22.3% and 35.3%, while fasting insulin levels were reduced by 34.2% and 62.6%, respectively. PF also markedly improved dyslipidemia, with serum TG, TC, and LDL-C levels reduced by 27.1%, 25.8%, and 25.0%, respectively, in the 100 mg/kg group and by 41.1%, 49.5%, and 42.6%, respectively, in the 200 mg/kg group. PF further reduced adipocyte hypertrophy and increased the expression of the browning-related markers UCP1, PGC-1α, and PRDM16 in inguinal white adipose tissue (iWAT). In differentiated 3T3-L1 adipocytes, PF reduced lipid accumulation, enhanced browning-related marker expression, and activated AMPK/SIRT3 signaling, whereas pharmacological inhibition of AMPK attenuated these effects. PF alleviates HFD-induced obesity and associated metabolic abnormalities, accompanied by enhanced iWAT browning and reduced lipid accumulation. These effects may be associated with activation of the AMPK/SIRT3 signaling pathway.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-14
DOI
https://doi.org/10.1038/s41598-026-78920-5
Primary Topic
Adipose Tissue and Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Paeoniflorin attenuates high-fat diet-induced obesity by promoting white adipose tissue browning via the regulation of the AMPK/SIRT3 pathway

Sun Mengyue, Wei Wang, Mengxi Wang, Shaohong Zhang et al.
1 links
Scientific Reports
Adipose Tissue and Metabolism
article

Paeoniflorin attenuates high-fat diet-induced obesity by promoting white adipose tissue browning via the regulation of the AMPK/SIRT3 pathway

Sun Mengyue, Wei Wang, Mengxi Wang, Shaohong Zhang, Litong Zhang, Yi Ni
article en

Abstract

Obesity is a major global public health challenge. Induction of white adipose tissue (WAT) browning has emerged as a potential strategy to enhance energy expenditure and improve metabolic homeostasis. Paeoniflorin (PF), a natural monoterpene glycoside, exhibits diverse pharmacological activities; however, its effects on WAT browning remain unclear. This study aimed to investigate whether PF alleviates high-fat diet (HFD)-induced obesity and associated metabolic abnormalities by promoting WAT browning. Obesity was induced in C57BL/6 mice by HFD feeding, followed by oral administration of PF (100 or 200 mg/kg). Body weight, adipose tissue mass, blood glucose, serum insulin, and lipid profiles were evaluated. Adipocyte morphology and the expression of thermogenesis-related markers, including UCP1, PGC-1α, and PRDM16, were assessed by histological analysis, RT-qPCR, Western blotting, and immunofluorescence staining. Lipid accumulation was evaluated by Oil Red O staining. In vitro, 3T3-L1 cells were treated with PF during adipocyte differentiation to assess lipid accumulation and the expression of browning-related markers. The potential involvement of the AMPK/SIRT3 signaling pathway was further investigated using pharmacological inhibition of AMPK. PF treatment significantly attenuated HFD-induced obesity and metabolic abnormalities in a dose-dependent manner. Compared with the HFD group, final body weight was reduced by 5.6% and 9.8% following treatment with PF at 100 and 200 mg/kg, respectively. Fasting blood glucose levels were decreased by 22.3% and 35.3%, while fasting insulin levels were reduced by 34.2% and 62.6%, respectively. PF also markedly improved dyslipidemia, with serum TG, TC, and LDL-C levels reduced by 27.1%, 25.8%, and 25.0%, respectively, in the 100 mg/kg group and by 41.1%, 49.5%, and 42.6%, respectively, in the 200 mg/kg group. PF further reduced adipocyte hypertrophy and increased the expression of the browning-related markers UCP1, PGC-1α, and PRDM16 in inguinal white adipose tissue (iWAT). In differentiated 3T3-L1 adipocytes, PF reduced lipid accumulation, enhanced browning-related marker expression, and activated AMPK/SIRT3 signaling, whereas pharmacological inhibition of AMPK attenuated these effects. PF alleviates HFD-induced obesity and associated metabolic abnormalities, accompanied by enhanced iWAT browning and reduced lipid accumulation. These effects may be associated with activation of the AMPK/SIRT3 signaling pathway.

Scientific Reports
Huaian First People’s Hospital (CN), Nanjing Medical University (CN)
National Natural Science Foundation of China, Nanjing Drum Tower Hospital
Good health and well-being
Adipose Tissue and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon